Navigation Links
Easily Amplify Genomic DNA with Long-Distance PCR


Using TaqPlus Long DNA polymerase to genotype mice

Evgeny Loukianov Tanya Loukianova Muthu Periasamy
Cardiovascular Research Center, University of Cincinnati, Cincinnati, OH

We developed a simple, reliable procedure to genotype mice using long-distance PCR, whereby genomic DNA is isolated from mouse ear clips, and large DNA fragments are amplified using TaqPlus Long DNA polymerase.*,,

PCR is the method of choice for screening transgenic mice1 because it is fast, allows a large number of samples to be screened at one time, is less laborious than Southern blotting, and does not require purified DNA or the use of radioactive materials. Genomic DNA for PCR screening of mice is generally prepared from tail biopsies2 or blood samples3; however, the routine procedure of clipping the ear or toe to mark the mice4 provides enough tissue to extract DNA for PCR amplification. The ear clip procedure is advantageous because not only are mice identified and genotyped simultaneously, they tolerate ear clipping better than cutting of the tail or toes.

In many cases, it is beneficial to amplify large DNA fragments to verify the structure of a modified genetic locus. For example, when using targeting vectors with long arms,5 conventional PCR is not suitable for mouse genotyping.6 Hence, we developed a procedure to amplify large DNA fragments with TaqPlus Long DNA polymerase using genomic DNA from mouse ear clips.

Genomic DNA Prepared from Mouse Ear Clips

The integrity of the DNA template is crucial for reproducible long-distance PCR.7 Because DNA prepared from ear clips by standard methods2,8 failed to provide reproducible amplification of large (1.5 kb) DNA fragments, we developed a
'"/>

Source:


Page: All 1 2 3 4 5 6 7

Related biology technology :

1. Printable CELLocate Log Sheets for Easily Locating Adhererent Cells
2. TripleMaster and Perfect gDNA Blood Mini Kit Team Up to Amplify Long gDNA Templates
3. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
4. New Protocols for Isolating High- Molecular-Weight Genomic DNA
5. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
6. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
7. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
8. Mouse Tail Genomic DNA Isolation Protocol(1)
9. Genomic DNA Isolation Protocol(1,2,3)
10. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
11. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Easily Amplify Genomic DNA with Long Distance PCR

(Date:11/5/2009)...URG, Md., Nov. 5 GenVec,...al results for the third quarter ended September 3...n ($0.04 per share) for the three months ended Sep...lion ($0.08 per share) in the comparable quarter o...09, GenVec,s net loss was $14.1 million ($0.15 per...
(Date:11/5/2009)...RDOVA, Calif., Nov. 5 Th...lier of innovative products for processing and sto...the first quarter of fiscal 2010. ,, For the qu...ed revenues of $5.2 million, a 15 percent increase...r a year ago. The Company said the key contributor...
(Date:11/5/2009)..., Calif., Nov. 5 Cepheid...ves will be speaking at the following investor con... webcast. , , Credit Suisse Health...sday, 12 November, 2009 at 10 a.m. Mountain Time,... London, England, Tuesday, 1 Decem...
(Date:11/5/2009)...exas, Nov. 5 SpineSmith Partners h... to co-develop a unique scaffold that mimics the s...aluation of several commercial products by SpineSm...pany believes the GenOsteo scaffold represents a s...a unique and ideal environment for the delivery of...
Breaking Biology Technology:GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Cepheid to Webcast Upcoming Financial Presentations 2SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...SAN DIEGO, March 2 BioMed Realty Trust, Inc. (NYS...cutive management will present at the Citi 2009 Gl... approximately 9:05 a.m. Eastern Standard Time on ...ll be open to all investors by calling 719.785.559...ioMed Realty Trust , BioMed Realty Trust, Inc. is...
..., Innovative B.C. Technology Promises to Revolu...ER, March 2 /PRNewswire-FirstCall/ - EnWave Corpor...ay announced that it has completed the first sale ...uipment to CAL-SAN Enterprises, Ltd. of Richmond, ...producers. With this sale, EnWave has proven that ...
... EXTON, Pa., March 2 Morphotek(R), Inc., a sub...ay announced that it has commenced a,multi-centere...ody in,mesothelioma. The study will evaluate MORAb...isplatinum, as a first-line treatment for patients... the study is to assess the efficacy of MORAb-009,...
Other Biology Technology:EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 2EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 3EnWave Successfully Commercializes nutraREV(TM) Food Dehydration Technology 4Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 2Morphotek(R), Inc. Announces Initiation of MORAb-009 Phase II Study in First- Line Treatment of Mesothelioma 3
(Date:11/4/2009)...an has received more than $10 million in research ...ederal stimulus program, bringing thetotal amount ...$23 million. Thirty-three projects achieved stimu...o weather. , "The university has thoughtfully un... scholarly excellence to federal agency priorities...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...wswire/ -- GenVault Corporation (Carlsbad, CA) tod...joined its Board of Directors. Dr. Brody, the Irw..., is an acclaimed physician-scientist and universi...r. Brody served as president of The Johns Hopkins ...y of Engineering and the Institute of Medicine, an...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Hormone therapy may confer more aggressive properties to prostate tumors 48453 1Drugs against winter vomiting disease one step closer 48451 1Drugs against winter vomiting disease one step closer 48451 2New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 1New Jefferson study may redefine how a chronic auto immune disease is diagnosed 48449 2
...immune system cells go through a laboratory versio...against HIV, believe University of Pittsburgh rese... development of a novel therapeutic vaccine loaded...hich have been galvanized to rally other cells of ...that individual. , At the XVI International AIDS ...
... the Harvard Department of Ophthalmology,s Schepen... Ear Infirmary (MEEI) are the first to learn why t... blood vessels--a unique phenomenon that makes vis... unexpected presence of large amounts of the prote...eptor-3) on the top epithelial layer of normal hea...
...e has its place and role in the oceans ?even the s... lead to more accurate models of ocean change. , ...que biological niche for most animals and plants ?...dolphin. , Bacteria instead have been relegated ... which few species are considered unique, said Jed...
Other Biology News:T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 2T cells activated to fight HIV basis for dendritic cell therapeutic vaccine 3Scientists discover why cornea is transparent and free of blood vessels, allowing vision 2Scientists discover why cornea is transparent and free of blood vessels, allowing vision 3Bacteria can help predict ocean change 2
Starter Accessory Package I from Bethyl Laboratories
Rabbit Anti-Human Purinergic Receptor P2Y12 Polyclonal Antibody, Unconjugated from IMGENEX
Rabbit Anti-Human CLAN Polyclonal Antibody, Unconjugated from IMGENEX
Acridinium Quench Solution from Cayman Chemical
Biology Products: